IT1304595B1 - Inibitore della 5-lipoossigenasi - Google Patents

Inibitore della 5-lipoossigenasi

Info

Publication number
IT1304595B1
IT1304595B1 IT1997TN000008A ITTN970008A IT1304595B1 IT 1304595 B1 IT1304595 B1 IT 1304595B1 IT 1997TN000008 A IT1997TN000008 A IT 1997TN000008A IT TN970008 A ITTN970008 A IT TN970008A IT 1304595 B1 IT1304595 B1 IT 1304595B1
Authority
IT
Italy
Prior art keywords
lonapalene
seems
side effects
lipooxygenase inhibitor
dimethoxynaphthalendioldiacetate
Prior art date
Application number
IT1997TN000008A
Other languages
English (en)
Inventor
Giorgio Endrici
Original Assignee
Giorgio Endrici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1997TN000008A priority Critical patent/IT1304595B1/it
Application filed by Giorgio Endrici filed Critical Giorgio Endrici
Priority to CN98808689A priority patent/CN1268887A/zh
Priority to BR9811402-6A priority patent/BR9811402A/pt
Priority to PCT/IT1998/000236 priority patent/WO1999011249A2/en
Priority to AU91836/98A priority patent/AU9183698A/en
Priority to DK98944203T priority patent/DK1011649T3/da
Priority to SI9830041T priority patent/SI1011649T1/xx
Priority to DE69803303T priority patent/DE69803303T2/de
Priority to PT98944203T priority patent/PT1011649E/pt
Priority to EP98944203A priority patent/EP1011649B1/en
Priority to ES98944203T priority patent/ES2165701T3/es
Priority to JP2000508352A priority patent/JP2001514214A/ja
Priority to US09/485,700 priority patent/US6291534B1/en
Priority to CA002302241A priority patent/CA2302241A1/en
Priority to AT98944203T priority patent/ATE209033T1/de
Publication of ITTN970008A1 publication Critical patent/ITTN970008A1/it
Priority to HK00108404A priority patent/HK1029058A1/xx
Application granted granted Critical
Publication of IT1304595B1 publication Critical patent/IT1304595B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
IT1997TN000008A 1997-08-29 1997-08-29 Inibitore della 5-lipoossigenasi IT1304595B1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT1997TN000008A IT1304595B1 (it) 1997-08-29 1997-08-29 Inibitore della 5-lipoossigenasi
ES98944203T ES2165701T3 (es) 1997-08-29 1998-08-27 Utilizacion de endipaleno para el tratamiento de la psoriasis.
PCT/IT1998/000236 WO1999011249A2 (en) 1997-08-29 1998-08-27 Use of endipalene in the treatment of psoriasis
AU91836/98A AU9183698A (en) 1997-08-29 1998-08-27 A new chemical entity (endipalene) in the treatment of psoriasis
DK98944203T DK1011649T3 (da) 1997-08-29 1998-08-27 Anvendelse af endipalen ved behandling af psoriasis
SI9830041T SI1011649T1 (en) 1997-08-29 1998-08-27 Use of endipalene in the treatment of psoriasis
DE69803303T DE69803303T2 (de) 1997-08-29 1998-08-27 Verwendung von endipalen zur behandlung von schuppenflechte
PT98944203T PT1011649E (pt) 1997-08-29 1998-08-27 Utilizacao de endipaleno no tratamento de psoriase
CN98808689A CN1268887A (zh) 1997-08-29 1998-08-27 治疗银屑病的新化合物
BR9811402-6A BR9811402A (pt) 1997-08-29 1998-08-27 Uso topicamente ou em outro modo administrado, de endipalene em qualquer concentração e em qualquer solvente
JP2000508352A JP2001514214A (ja) 1997-08-29 1998-08-27 乾癬の治療における新規な化学物質（エンディパレン）
US09/485,700 US6291534B1 (en) 1997-08-29 1998-08-27 Chemical entity (endipalene) in the treatment of psoriasis
CA002302241A CA2302241A1 (en) 1997-08-29 1998-08-27 A new chemical entity (endipalene) in the treatment of psoriasis
AT98944203T ATE209033T1 (de) 1997-08-29 1998-08-27 Verwendung von endipalen zur behandlung von schuppenflechte
EP98944203A EP1011649B1 (en) 1997-08-29 1998-08-27 Use of endipalene in the treatment of psoriasis
HK00108404A HK1029058A1 (en) 1997-08-29 2000-12-27 Use of endipalene in the treatment of psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1997TN000008A IT1304595B1 (it) 1997-08-29 1997-08-29 Inibitore della 5-lipoossigenasi

Publications (2)

Publication Number Publication Date
ITTN970008A1 ITTN970008A1 (it) 1999-03-01
IT1304595B1 true IT1304595B1 (it) 2001-03-19

Family

ID=11408676

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1997TN000008A IT1304595B1 (it) 1997-08-29 1997-08-29 Inibitore della 5-lipoossigenasi

Country Status (15)

Country Link
US (1) US6291534B1 (it)
EP (1) EP1011649B1 (it)
JP (1) JP2001514214A (it)
CN (1) CN1268887A (it)
AT (1) ATE209033T1 (it)
AU (1) AU9183698A (it)
BR (1) BR9811402A (it)
CA (1) CA2302241A1 (it)
DE (1) DE69803303T2 (it)
DK (1) DK1011649T3 (it)
ES (1) ES2165701T3 (it)
HK (1) HK1029058A1 (it)
IT (1) IT1304595B1 (it)
PT (1) PT1011649E (it)
WO (1) WO1999011249A2 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675056B2 (en) * 1991-11-12 1997-01-23 Protein Polymer Technologies, Inc. High molecular weight collagen-like protein polymers
PT2123265E (pt) * 2008-05-23 2012-08-06 Novaera S R L Formulações de endipaleno no tratamento da psoríase
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732964B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux amides tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
US6156790A (en) * 1997-12-30 2000-12-05 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities

Also Published As

Publication number Publication date
ES2165701T3 (es) 2002-03-16
BR9811402A (pt) 2000-08-29
ITTN970008A1 (it) 1999-03-01
WO1999011249A3 (en) 1999-09-16
US6291534B1 (en) 2001-09-18
AU9183698A (en) 1999-03-22
WO1999011249A2 (en) 1999-03-11
CN1268887A (zh) 2000-10-04
ATE209033T1 (de) 2001-12-15
DE69803303D1 (de) 2002-02-21
DE69803303T2 (de) 2002-05-02
JP2001514214A (ja) 2001-09-11
EP1011649A2 (en) 2000-06-28
DK1011649T3 (da) 2002-05-21
EP1011649B1 (en) 2001-11-21
HK1029058A1 (en) 2001-03-23
CA2302241A1 (en) 1999-03-11
PT1011649E (pt) 2002-05-31

Similar Documents

Publication Publication Date Title
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
WO2000038717A3 (en) Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
ATE303156T1 (de) Verwendung von gnrh-analogue zur behandlung der harninkontinenz
IT1302060B1 (it) Dispositivo per il trattamento di moxa del tipo shiatsu.
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DK0739212T3 (da) Anvendelse af interleukin-12 til forebyggelse af transplantat-vs.-værtssygdom
DK0909556T3 (da) Rosaceae-ekstrakt som bradykininantagonist
AR037524A1 (es) Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
PT1242410E (pt) Compostos novos
IT1304595B1 (it) Inibitore della 5-lipoossigenasi
PT1124566E (pt) Laxativo osmotico nao fermentado para o tratamentoe a prevencao dos cancros colorectais
PA8453601A1 (es) Inhibidores de la farnesil transferasa combinados con inhibidores de la hmg coa reductasa para tratamiento del cancer
DK0509120T3 (da) Topisk anvendelse af glycosaminoglycaner til forebyggelse og behandling af sygdomme, der påvirker det cervikale vaginale område
BR0307317A (pt) Tratamento de combinação para infartação miocardial aguda
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
IT1289845B1 (it) Formula per il trattamento della cute e suoi impieghi
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
SE9800139D0 (sv) New use
YU31104A (sh) Inhibicija virusa n-dokozanolom
BR0009289A (pt) Uso de inibidores da vasopeptidase para tratar angina pectoris
ES2183977T3 (es) Combinacion de temozolomida y alfa-interferon para el tratamiento de cancer avanzado.
EP0642793A4 (en) Apoptosis inducer.